Podcast

Best Practices in the Pharmacologic Reversal of Neuromuscular Blockade

Launch Date
10/19/2023 at 4:00 am EST
Credit Amount
0.75
Credit Expires
10/19/2024
This activity is part of a series

Faculty

J. Ross Renew, MD, FASA, FASE
Associate Professor of Anesthesiology
Mayo Clinic College of Medicine and Science
Vice Chair of Research, Department of Anesthesiology and Perioperative Medicine
Mayo Clinic
Jacksonville, FL
J. Ross Renew, MD, FASA, FASE

Ross Renew, MD, FASA, FASE, graduated from Clemson University (Chemistry, BS) and completed medical school at the University of South Carolina School of Medicine. Dr. Renew completed anesthesia residency at Mayo Clinic Florida and his fellowship in adult cardiothoracic anesthesiology at Mayo Clinic in Rochester, MN. Dr. Renew then returned to Jacksonville and has worked on staff at Mayo Clinic Florida, where he is currently an Associate Professor of Anesthesiology. Dr. Renew serves as the Vice Chair of Research and Associate Program Director for the department’s residency program.  His research interests involve neuromuscular blockade and monitoring, transesophageal echocardiography, and caring for the cardiac patient undergoing non-cardiac surgery.

Ian A. Makey, MD
Associate Professor, Department of Surgery
Mayo Clinic College of Medicine and Science
Cardiothoracic Surgeon
Mayo Clinic
Jacksonville, FL
Ian A. Makey, MD

Dr. Ian Makey is a cardiothoracic surgeon at Mayo Clinic Florida.  He specializes in robotic thoracic surgery and lung transplantation.

Dru Riddle, PhD, DNP, CRNA, FAAN
Associate Professor & Director of Clinical Education
School of Nurse Anesthesia
Texas Christian University
Fort Worth, TX
Dru Riddle, PhD, DNP, CRNA, FAAN

Dru is an academic and clinically-practicing Certified Registered Nurse Anesthetist (CRNA) and American Association of Nurse Anesthesiology (AANA) President.  He also serves as co-chair of the Cochrane US Network.

Explore By Section
Statement of Need Learning Objective Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

Early in 2023, new guidelines were published by the American Society of Anesthesiologists (ASA) to provide best practices in the monitoring and reversal of neuromuscular blockade. A key component of these updated guidelines was the appropriate use of an antagonist agent, including appropriate choice and dosage of a therapeutic agent. While the selection of a reversal agent is highly dependent on an accurate assessment of the depth of neuromuscular blockade, the relationship between the depth of blockade and pharmacologic antagonism is not well understood by many clinicians, resulting in inappropriate therapy selection and inappropriate dosing.

In the final episode of this CMEOCast podcast series, expert faculty will discuss the use of deep neuromuscular blockade to facilitate optimal surgical conditions and provide learners with strategies to effectively utilize best practices in the pharmacologic reversal of neuromuscular blockade ideally guided by quantitative monitoring techniques.

Learning Objective

Utilize best practices in the pharmacologic reversal of neuromuscular blockade.

Financial Support

Supported by an educational grant from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.

Target Audience

Physicians, nurse practitioners (NPs), physician associates (PAs), nurses, and pharmacists specializing in anesthesiology or surgery

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional (IPCE) 0.75

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) Credit for learning and change.

Physicians (ACCME) 0.75

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Outfitters, LLC, designates this enduring activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 0.75

This activity is designated for 0.75 contact hour. Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Pharmacists (ACPE) 0.75

This application-based activity is approved for 0.75 contact hour (0.075 CEUs) of continuing pharmacy credit.
Activity UAN: JA0007185-0000-23-108-H01-P

Physician Assistants (AAPA): 0.75

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.

Anesthesiology (ABA MOC)

This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology (TM) (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.

Surgeons (ABS CC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.

Dr. Renew reports the following financial relationships:

Research Support: Merck & Co., Inc (Funds to Mayo Clinic)

Dr. Makey reports no financial relationships to disclose.

Dr. Riddle reports the following financial relationships:

Speakers Bureau: Acacia Pharma/Eagle Pharmaceuticals, Inc.

Disclosures were obtained from the following peer reviewer and CME Outfitters, LLC, staff, with no disclosures to report:

  • Jeffrey Helfand, DO
  • Michael Franks, APRN, AGACNP-BC, FNP-BC (peer reviewer)
  • Morgan Stockberger, MD (planning committee)
  • Kasey Brandt, PharmD (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

PD-097-101923-44

Best Practices in the Pharmacologic Reversal of Neuromuscular Blockade
Event Date: 10/19/2023 at 4:00 am EST
Register

Activities in the Series

08/31/2023 at 4:00 am EST

Improving Patient Outcomes with Quantitative TOF Monitoring

0.75
Register Learn More
09/26/2023 at 4:00 am EST

Best Practices in Neuromuscular Monitoring: A Focus On 2023 ASA Guidelines

0.75
Register Learn More